ClinicalTrials.gov

History of Changes for Study: NCT00840710
Clinical Feasibility of Birth- Track II System (BT)
Latest version (submitted December 27, 2009) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 February 9, 2009 None (earliest Version on record)
2 December 27, 2009 Recruitment Status and Study Status
Comparison Format:

Scroll up to access the controls

Study NCT00840710
Submitted Date:  December 27, 2009 (v2)

Open or close this module Study Identification
Unique Protocol ID: BT-II-IS-001
Brief Title: Clinical Feasibility of Birth- Track II System (BT)
Official Title: Clinical Feasibility of Birth- Track II System
Secondary IDs:
Open or close this module Study Status
Record Verification: February 2009
Overall Status: Unknown status [Previously: Not yet recruiting]
Study Start: February 2010
Primary Completion:
Study Completion: August 2010 [Anticipated]
First Submitted: February 8, 2009
First Submitted that
Met QC Criteria:
February 9, 2009
First Posted: February 10, 2009 [Estimate]
Last Update Submitted that
Met QC Criteria:
December 27, 2009
Last Update Posted: December 29, 2009 [Estimate]
Open or close this module Sponsor/Collaborators
Sponsor: Barnev Ltd
Responsible Party:
Collaborators:
Open or close this module Oversight
U.S. FDA-regulated Drug:
U.S. FDA-regulated Device:
Data Monitoring: No
Open or close this module Study Description
Brief Summary: The Study purpose is to monitor the cervix dilation, head descent, FHR and to follow contraction in a women in active labor.
Detailed Description:
Open or close this module Conditions
Conditions: Obstetrics
Labor
Keywords: women in active labor
Open or close this module Study Design
Study Type: Observational
Observational Study Model: Cohort
Time Perspective: Cross-Sectional
Biospecimen Retention:
Biospecimen Description:
Enrollment: 15 [Anticipated]
Number of Groups/Cohorts 0
Open or close this module Groups and Interventions
Open or close this module Outcome Measures
Open or close this module Eligibility
Study Population: Women in active labor
Sampling Method: Non-Probability Sample
Minimum Age: 17 Years
Maximum Age: 50 Years
Sex: Female
Gender Based:
Accepts Healthy Volunteers: Yes
Criteria:

Inclusion Criteria:

  1. Laboring women referred to the Maternity Center in active labor (3cm dilatation and contractions).
  2. Gestational age 37-42 weeks. (GA)
  3. Single fetus
  4. Subjects who understood, agreed and signed the informed consent form

Exclusion Criteria:

  1. Women with abnormal placentation (placenta previa)
  2. Abnormal fetal presentation (breech presentation)
  3. Maternal History of HIV and/or blood transmitted hepatitis and/or active genital Herpes.
  4. Need for immediate delivery (cord prolapsed or suspected placental abruption)
Open or close this module Contacts/Locations
Study Officials: Jacob Bornstein, PhD
Principal Investigator
Westren Gallilie Hospital
Locations: Israel
Westren Gallilie Hospital
Nahariya, Israel
Contact:Principal Investigator: Jacob Bornstein, Phd
Open or close this module IPDSharing
Plan to Share IPD:
Open or close this module References
Citations:
Links:
Available IPD/Information:

Scroll up to access the controls Scroll to the Study top

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services